EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Familial Partial Lipodystrophy: Clinical Features, Genetics and Treatment in a Greek Referral Center

Aikaterini Kountouri iD, Emmanouil Korakas iD, Eirini Maratou, Ignatios Ikonomidis iD, Konstantinos Balampanis, Stavros Liatis, Nikolaos Tentolouris, Panagiotis Toulas, Foteini Kousathana, Christophoros Giatzakis, George D Dimitriadis iD, Vaia Lambadiari

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241512045 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Aikaterini Kountouri und 11 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 12462 Athens, Gr…. Hauptthemen laut MEDLINE: Lipodystrophy, Familial Partial. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial partial lipodystrophy (FPLD) is a rare syndrome in which a patient’s phenotype is not merely dependent on the specific genetic mutation, but it is also defined by a combination of other demographic, environmental and genetic factors. In this prospective observational study in a Greek referral center, we enrolled 39 patients who fulfilled the clinical criteria of FPLD. A genetic analysis was conducted, which included sequence and deletion/duplication analyses of the LMNA and PPRARG genes, along with anthropometric and metabolic parameters. The treatment responses of patients who were eligible for treatment with metreleptin were evaluated at 3 and 12 months. In most of the patients, no significant changes were detected at the exon level, and any mutations that led to changes at the protein level were not associated with the lipodystrophic phenotype. On the contrary, various changes were detected at the intron level, especially in introns 7 and 10, whose clinical significance is considered unknown. In addition, treatment with metreleptin in specific FPLD patients significantly improved glycemic and lipidemic control, an effect which was sustained at the 12-month follow-up. More large-scale studies are necessary to clarify the genetic and allelic heterogeneity of the disease, along with other parameters which could predict treatment response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipodystrophy, Familial PartialHumansGreeceLamin Type AMutationPhenotype

Stichwörter der Autor:innen

FPLDdiabetes mellitusexonshypertriglyceridemiainsulin resistanceintronslipodystrophymetreleptin

Substanzen

Lamin Type A

Autor:innen und Institutionen

  • Second Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 12462 Athens, Greece.
  • Laboratory of Clinical Biochemistry, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 12462 Athens, Greece.
  • Laboratory of Preventive Cardiology, Second Cardiology Department, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 12462 Athens, Greece.
  • First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece.
  • Bioiatriki Healthcare Group, 11526 Athens, Greece.
  • DNAbiolab, Cretan Center for Research and Development of Applications on Genetics and Molecular Biology, 71306 Heraklion, Greece.

ORCID-Profile: Aikaterini Kountouri, Emmanouil Korakas, Ignatios Ikonomidis, George D Dimitriadis

Zitieren

APA

Kountouri, A., Korakas, E., Maratou, E., Ikonomidis, I., Balampanis, K., Liatis, S., Tentolouris, N., Toulas, P., Kousathana, F., Giatzakis, C., Dimitriadis, G. D., & Lambadiari, V. (2023). Familial Partial Lipodystrophy: Clinical Features, Genetics and Treatment in a Greek Referral Center. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241512045

Vancouver

Kountouri A, Korakas E, Maratou E, Ikonomidis I, Balampanis K, Liatis S, et al. Familial Partial Lipodystrophy: Clinical Features, Genetics and Treatment in a Greek Referral Center. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241512045

BibTeX
@article{Kountouri2023,
  author = {Kountouri, Aikaterini and Korakas, Emmanouil and Maratou, Eirini and Ikonomidis, Ignatios and Balampanis, Konstantinos and Liatis, Stavros and Tentolouris, Nikolaos and Toulas, Panagiotis and Kousathana, Foteini and Giatzakis, Christophoros and Dimitriadis, George D and Lambadiari, Vaia},
  title = {Familial Partial Lipodystrophy: Clinical Features, Genetics and Treatment in a Greek Referral Center},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241512045}
}
Kostenlos starten →